发明名称 Oral supplement of six selective amino acids arrest progression renal failure, cholesterolaemia, albuminuria, phosphataemia and atherosclerosis in uraemic patients
摘要 ertain amino acid taken orally from normal adults or patients with renal failure as increase glomerular filtration rate (GFR) as glycine, L-aspartic acid, L-glutamic acid, L-glutamine, L-histidine and L-arginine, according our study, have, potent scavergering activity and useful beneficial properties, prompted us to perform the present investigation. Annual use of proposed supplement arrests progression renal failure, cholesterolaemia, albuminuria, phosphataemia and atherosclerosis. Chemical and histological findings after one year treatment were improved considerably. Interestingly, 3 months after stoping treatment, chemical profile of all parameters remain approximately unchanged, that means, not only supplement arrests the above important parameters, but may cure the restoration of older lessions.
申请公布号 GR1004319(B) 申请公布日期 2003.08.28
申请号 GR20020100343 申请日期 2002.07.22
申请人 GIATZIDIS IPPOKRATIS ALEXANDROU 发明人 GIATZIDIS IPPOKRATIS ALEXANDROU
分类号 A61K31/195;A61K31/198;A61K31/4172;A61P13/12 主分类号 A61K31/195
代理机构 代理人
主权项
地址